Search - tctmd.com

Displaying 41 - 60 of 3682

Sort: Relevancy | Date

News Daily News

Sin ECA, el Análisis de Emparejamiento por Puntuación de la Propensión permite tomar una Decisión Informada entre Cangrelor y GPI en el Laboratorio de Cateterización

Yael L. Maxwell

December 06, 2016

News Daily News

Patients With A-fib Still Have High Mortality Risk After Appropriate Anticoagulation Is Started

Todd Neale

December 05, 2016

News Daily News

FDA Approves CV Death Reduction Claim for Empagliflozin in Type 2 Diabetes

Shelley Wood

December 02, 2016

News Daily News

Smoking and Acute MI: The Younger the Patient, the Higher the Risk

L.A. McKeown

December 02, 2016

News Daily News

USPSTF: Counseling on Diet and Exercise Helpful but Not Mandatory for CVD Prevention

Caitlin E. Cox

December 02, 2016

News Opinion Fellow Talk

The US Presidential Election Rhetoric: Not the America I Know

Ankur Kalra

December 02, 2016

News Daily News

Testosterone Therapy Raises Risk of VTE Early but Not Beyond 6 Months

Michael O'Riordan

December 01, 2016

PCSK9 Variants Linked With Lower LDL Cholesterol, Increased Diabetes Risk

News Daily News

PCSK9的变体与低LDL胆固醇和糖尿病风险增加相关

Michael O'Riordan

December 01, 2016

News Daily News

PCSK9 Variants Linked With Lower LDL Cholesterol, Increased Diabetes Risk

Michael O'Riordan

December 01, 2016

News Daily News

Las Variantes del Gen PCSK9 se asocian a Niveles Más Bajos de Colesterol LBD y a un Mayor Riesgo de Diabetes

Michael O'Riordan

December 01, 2016

News Daily News

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

L.A. McKeown

December 01, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2016

Shelley Wood

November 30, 2016

Podcast Heart Sounds

脂质损失：国家数据显示总胆固醇、甘油三酯和低密度脂蛋白大大降低

Yael L. Maxwell

November 30, 2016

News Daily News

Pérdidas Lipídicas: Datos a Nivel Nacional Revelan Descensos Drásticos de Colesterol Total, Triglicéridos y LBD

Yael L. Maxwell

November 30, 2016

News Daily News

Lipid Losses: National Data Show Drastic Drops in Total Cholesterol, Triglycerides, and LDL

Yael L. Maxwell

November 30, 2016

News Industry News

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

November 29, 2016

News Conference News AHA 2016

鉴于动脉粥样硬化 CVD 的上升趋势，治疗成本应该刺激政策制定者推广预防

Yael L. Maxwell

November 29, 2016

News Conference News AHA 2016

En mitad de la Marea Creciente de ECVA, los Costes del Tratamiento Deberían hacer que los Legisladores Legislasen en Materia de Prevención

Yael L. Maxwell

November 29, 2016

News Conference News AHA 2016

Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention

Yael L. Maxwell

November 29, 2016

Advertisement

Sin ECA, el Análisis de Emparejamiento por Puntuación de la Propensión permite tomar una Decisión Informada entre Cangrelor y GPI en el Laboratorio de Cateterización

Patients With A-fib Still Have High Mortality Risk After Appropriate Anticoagulation Is Started

FDA Approves CV Death Reduction Claim for Empagliflozin in Type 2 Diabetes

Smoking and Acute MI: The Younger the Patient, the Higher the Risk

USPSTF: Counseling on Diet and Exercise Helpful but Not Mandatory for CVD Prevention

The US Presidential Election Rhetoric: Not the America I Know

Testosterone Therapy Raises Risk of VTE Early but Not Beyond 6 Months

PCSK9的变体与低LDL胆固醇和糖尿病风险增加相关

PCSK9 Variants Linked With Lower LDL Cholesterol, Increased Diabetes Risk

Las Variantes del Gen PCSK9 se asocian a Niveles Más Bajos de Colesterol LBD y a un Mayor Riesgo de Diabetes

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

TCTMD’s Top 10 Most Popular Stories for November 2016

Top Stories in Cardiology: November 2016

脂质损失：国家数据显示总胆固醇、甘油三酯和低密度脂蛋白大大降低

Pérdidas Lipídicas: Datos a Nivel Nacional Revelan Descensos Drásticos de Colesterol Total, Triglicéridos y LBD

Lipid Losses: National Data Show Drastic Drops in Total Cholesterol, Triglycerides, and LDL

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

鉴于动脉粥样硬化 CVD 的上升趋势，治疗成本应该刺激政策制定者推广预防

En mitad de la Marea Creciente de ECVA, los Costes del Tratamiento Deberían hacer que los Legisladores Legislasen en Materia de Prevención

Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content